<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738735</url>
  </required_header>
  <id_info>
    <org_study_id>2018Davis</org_study_id>
    <nct_id>NCT03738735</nct_id>
  </id_info>
  <brief_title>Randomized, Controlled Trial of Hyperosmotlar Saline for Rotator Cuff Repair Irrigation Solution</brief_title>
  <official_title>Prospective, Double Blinded, Randomized Control Trial on Effect of Hyperosmlar Saline in Reducing Postoperative Pain Following Arthroscopic Rotator Cuff Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to perform a randomized, double-blinded study investigating
      postoperative pain after arthroscopic rotator cuff using hyperosmolar saline as opposed to
      lactated ringer's solution (normal osmolarity) as arthroscopy irrigation solutions.
      Hyperosmolar saline is an irrigation solution with a higher concentration of solutes that
      will be used intraoperatively to washout the surgical field. It will be used in place of
      lactated ringer's solution, which has an osmolarity comparable to that of normal saline. This
      study will help determine whether or not postoperative pain from rotator cuff repair can be
      mitigated by altering the osmolarity of the intraoperative irrigation solution. This
      knowledge is significant because the postoperative pain can be intense, so much so that
      patients may depend on narcotics for pain relief. Consequently, this study may provide
      benefit by helping to find new ways to minimize the need for narcotics. The main hypothesis
      of this is study is that hyperosmolar saline will reduce perceived pain and narcotic use in
      the postoperative period.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>daily for 14 days post-operatively</time_frame>
    <description>pain rated on scale of 1-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphine equivalent</measure>
    <time_frame>weekly for first 2 weeks post-operatively</time_frame>
    <description>opiod comsumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Shoulder Elbow Surgeons standardized shoulder assessment form</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>shoulder function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Passive range of motion</measure>
    <time_frame>6 weeks, 3 months, 6 months</time_frame>
    <description>passive range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Active range of motion</measure>
    <time_frame>3 months, 6 months</time_frame>
    <description>Active range of motion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Arthroscopic Shoulder Surgery</condition>
  <condition>Rotator Cuff Tear</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive standard of care lactated ringer's solution for the arthroscopic irrigation during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive hyperosmolar saline for the arthroscopic irrigation during surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hypertonic saline</intervention_name>
    <description>For the intervention group, the surgical staff will add 120 mL of 23.4% saline to the 3L bags of lactated Ringer's solution, and this new solution will be used for arthroscopic irrigation purposes throughout the rotator cuff repair surgery.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age &gt; 18 years of age

        Patients undergoing arthroscopic rotator cuff repair of full thickness, one or two tendon
        tears

        Exclusion Criteria:

        Patients younger than 18 years of age

        Patients who are pregnant, mentally disabled, or imprisoned

        Patients not receiving inter-scalene nerve block (catheters excluded)

        Patients undergoing labral repair, capsular release, or distal clavicle excision

        Patients with irreparable rotator cuff tears

        Patients receiving any repair augmentation or graft

        Patients with a known hypersensitivity to sodium lacta
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Cox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Davis, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rothman Orthopaedics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liam Kane, BS</last_name>
    <phone>2673393593</phone>
    <email>Liam.Kane@rothmanortho.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thema Nicholson</last_name>
    <phone>2673393615</phone>
    <email>thema.nicholson@rothmanortho.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Capito NM, Cook JL, Yahuaca B, Capito MD, Sherman SL, Smith MJ. Safety and efficacy of hyperosmolar irrigation solution in shoulder arthroscopy. J Shoulder Elbow Surg. 2017 May;26(5):745-751. doi: 10.1016/j.jse.2017.02.021. Epub 2017 Mar 18.</citation>
    <PMID>28318850</PMID>
  </reference>
  <reference>
    <citation>Capito NM, Smith MJ, Stoker AM, Werner N, Cook JL. Hyperosmolar irrigation compared with a standard solution in a canine shoulder arthroscopy model. J Shoulder Elbow Surg. 2015 Aug;24(8):1243-8. doi: 10.1016/j.jse.2014.12.027. Epub 2015 Feb 25.</citation>
    <PMID>25725966</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

